Green Thumb Industries (GTBIF) Share-based Compensation Growth (1y) (2020 - 2026)
Green Thumb Industries (GTBIF) Share-based Compensation Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 281.05% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 61.54% |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 390.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 390.31% |
| Sep 30, 2025 | 39.59% |
| Jun 30, 2025 | 34.97% |
| Mar 31, 2025 | 58.84% |
| Dec 31, 2024 | 30.64% |
| Sep 30, 2024 | 15.72% |
| Jun 30, 2024 | 20.12% |
| Mar 31, 2024 | 4.02% |
| Dec 31, 2023 | -5.45% |
| Sep 30, 2023 | -8.42% |
| Jun 30, 2023 | 8.02% |
| Mar 31, 2023 | -52.41% |
| Dec 31, 2022 | 58.67% |
| Sep 30, 2022 | 57.72% |
| Jun 30, 2022 | 20.47% |
| Mar 31, 2022 | 225.25% |
| Dec 31, 2021 | 18.76% |
| Sep 30, 2021 | 12.61% |
| Jun 30, 2021 | -0.49% |
| Mar 31, 2021 | -55.05% |